Compare iShares MBS ETF (MBB) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MBS ETF vs Zimmer Biomet Holdings Inc — how do they compare? iShares MBS ETF trades at $93.39, while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Zimmer Biomet Holdings Inc pays a 1.07% dividend while iShares MBS ETF pays none, and Zimmer Biomet Holdings Inc is trading nearer its 52-week high, iShares MBS ETF nearer its low. Which is the better fit depends on your goals.
| MBB | ZBH | |
|---|---|---|
52-Week High | $96.91 | $107.71 |
52-Week Low | $92.92 | $79.58 |
Market Cap | — | $17.36B |
Sector | — | Health |
Enterprise Value | — | $24.40B |
Dividend Yield | — | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MBB (iShares MBS ETF) trades at $93.57, down 0.22% on the day, with a bearish technical signal from moving averages. The ETF shows neutral oscillator readings and has upcoming dividend payments. Recent news highlights institutional activity, including Comerica Bank reducing its stake while Concurrent Investment Advisors and Aureum Wealth increased positions in Q4 2026.
The outlook remains cautious due to bearish technical trends and mixed institutional sentiment. Risks include interest rate sensitivity impacting mortgage-backed securities. Opportunities lie in steady dividend income, but investors should monitor Federal Reserve policy shifts for potential volatility in the MBS market.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MBS ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index and TBAs that have economic characteristics that are substantially identical to the economic characteristics of the component securities of the index, and the fund will invest at least 90% of its assets in fixed income securities included in the underlying index that advisor believes will help the fund track the index.
Read more on MBB →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
